Business Context and Reporting Period
Company: American Shared Hospital Services
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2002
Business Overview: The Company provides Gamma Knife radiosurgery units to medical centers. As of March 31, 2002, it operated 12 units across 11 states. Revenue models include fee-per-use contracts and revenue-sharing ("retail") agreements. The Company also holds interests in startup subsidiaries OR21 and MedLeader, though development for MedLeader has been deferred.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Revenues (Medical Services) | $3,245,000 | $2,860,000 |
| Net Income | $320,000 | $417,000 |
| Earnings Per Share (Basic) | $0.09 | $0.12 |
| Earnings Per Share (Diluted) | $0.06 | $0.08 |
| Net Cash from Operating Activities | $648,000 | $1,200,000 |
| Cash and Cash Equivalents (End of Period) | $11,041,000 | $12,214,000 |
| Total Debt (Current + Long-term) | $25,624,000 | N/A |
| Working Capital | $8,739,000 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased by $385,000 (13.5%) driven by the addition of two new Gamma Knife units and a 2% increase in utilization at existing centers. Total procedures rose to 410 from 345.
- Profitability Decline: Net income decreased by $97,000 (23.3%) despite revenue growth. This was primarily due to the recognition of $105,000 in income tax expense (compared to $0 in Q1 2001) and a $112,000 reduction in interest and other income.
- Expense Trends:
- Costs of Operations: Increased $216,000, largely due to higher depreciation/amortization ($158,000 increase) from new units and equipment upgrades.
- Selling & Administrative: Decreased $11,000, primarily due to a $100,000 reduction in development costs for the MedLeader subsidiary.
- Interest Expense: Increased $38,000 due to financing for new units.
- Cash Flow: Net cash provided by operating activities decreased by $552,000, attributed to a $355,000 increase in accounts receivable and a reduction in accounts payable.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes cash flow from operations and existing cash resources ($11.0 million) are adequate to meet scheduled debt obligations of approximately $6.86 million due in the next 12 months.
- Strategic Shifts: The Company has deferred development of the MedLeader subsidiary to reduce costs. It continues to invest in Gamma Knife expansion, evidenced by a $100,000 deposit on a new unit.
- Tax Position: The Company began recording a 40% income tax provision in Q2 2001 after utilizing net operating loss carryforwards. The effective tax rate for Q1 2002 was approximately 25% due to a tax benefit from stock option exercises.
- Accounting Updates: The Company noted the adoption of new FASB statements (SFAS 141, 142, 143, 144) but does not expect them to have a material effect on its financial position.
- Risks: No legal proceedings or defaults on senior securities were reported. The primary financial risk remains the ability to service debt obligations, though management asserts sufficiency of funds.
Investor Verification Checklist
- Debt Service Coverage: Verify the adequacy of the $11.0 million cash balance against the $6.86 million in scheduled debt payments due within 12 months.
- Revenue Quality: Confirm the mix of fee-per-use versus revenue-sharing contracts and the stability of the 12 Gamma Knife unit network.
- Tax Liability: Monitor the sustainability of the effective tax rate, noting the one-time $65,000 benefit from option exercises in Q1 2002.
- Startup Costs: Assess the long-term viability of the deferred MedLeader project and the impact of the $100,000 deposit on the new Gamma Knife unit on future cash flows.
- Accounts Receivable: Review the $355,000 increase in receivables to ensure collection trends remain healthy as revenue grows.